- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Baudax Bio Stock (NASDAQ:BXRX), Quotes and News Summary
Baudax Bio Stock (NASDAQ: BXRX)
| Day Range0.23 - 0.25 | 52 Wk Range0.16 - 5.85 | Open / Close0.25 / 0.23 | Float / Outstanding8.1M / 8.2M |
| Vol / Avg.373.5K / 1.6M | Mkt Cap1.9M | P/E0.09 | 50d Avg. Price0.54 |
| Div / Yield- | Payout Ratio- | Total Float8.1M | EPS-1.05 |
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-03 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.270 | -0.690 | 0.5800 | ||||
| REV | 770.000K | 300.000K | -470.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Baudax Bio Questions & Answers
You can purchase shares of Baudax Bio (NASDAQ: BXRX) through any online brokerage.
Other companies in Baudax Bio’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Kiora Pharmaceuticals (NASDAQ:KPRX), Palisade Bio (NASDAQ:PALI), Sonoma Pharmaceuticals (NASDAQ:SNOA) and Evoke Pharma (NASDAQ:EVOK).
The latest price target for Baudax Bio (NASDAQ: BXRX) was reported by Oppenheimer on Monday, May 11, 2020. The analyst firm set a price target for 14.00 expecting BXRX to rise to within 12 months (a possible 5872.70% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Baudax Bio (NASDAQ: BXRX) is $0.2344 last updated September 29, 2022, 8:00 PM UTC.
There are no upcoming dividends for Baudax Bio.
Baudax Bio’s Q3 earnings are confirmed for Thursday, November 3, 2022.
There is no upcoming split for Baudax Bio.
Baudax Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.